Skip to main content

Table 2 Summary of patients with Tumor necrosis information. Good Responders: > 90% tumor necrosis; Poor Responders: ≤ 90% tumor necrosis

From: Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients

Dataset # Poor Responders # Good Responders Total # of patients
TARGET 26 18 44
INOVA 9 6 15